These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7767996)
1. Binding of the transcription factor, Sp1, to non-target sites in DNA modified by benzo[a]pyrene diol epoxide. MacLeod MC; Powell KL; Tran N Carcinogenesis; 1995 May; 16(5):975-83. PubMed ID: 7767996 [TBL] [Abstract][Full Text] [Related]
2. Interference of benzo[a]pyrene diol epoxide-deoxyguanosine adducts in a GC box with binding of the transcription factor Sp1. MacLeod MC; Powell KL; Kuzmin VA; Kolbanovskiy A; Geacintov NE Mol Carcinog; 1996 May; 16(1):44-52. PubMed ID: 8634093 [TBL] [Abstract][Full Text] [Related]
3. High-affinity binding of the cell cycle-regulated transcription factors E2F1 and E2F4 to benzo[a]pyrene diol epoxide-DNA adducts. Johnson DG; Coleman A; Powell KL; MacLeod MC Mol Carcinog; 1997 Oct; 20(2):216-23. PubMed ID: 9364211 [TBL] [Abstract][Full Text] [Related]
4. Disruption of transcription in vitro and gene expression in vivo by DNA adducts derived from a benzo[a]pyrene diol epoxide located in heterologous sequences. Butler AP; Johnson DG; Kumar AP; Narayan S; Wilson SH; MacLeod MC Carcinogenesis; 1997 Feb; 18(2):239-44. PubMed ID: 9054613 [TBL] [Abstract][Full Text] [Related]
5. Differences in the rate of DNA adduct removal and the efficiency of mutagenesis for two benzo[a]pyrene diol epoxides in CHO cells. MacLeod MC; Daylong A; Adair G; Humphrey RM Mutat Res; 1991 Dec; 261(4):267-79. PubMed ID: 1722282 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of covalent adducts derived from the binding of benzo[a]pyrene diol expoxide to a -GGG- sequence in a deoxyoligonucleotide. Mao B; Xu J; Li B; Margulis LA; Smirnov S; Ya NQ; Courtney SH; Geacintov NE Carcinogenesis; 1995 Feb; 16(2):357-65. PubMed ID: 7859369 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of benzo[a]pyrene diol epoxide mutagenicity by sulfite in a mammalian test system. Reed GA; Jones BC Carcinogenesis; 1996 May; 17(5):1063-8. PubMed ID: 8640914 [TBL] [Abstract][Full Text] [Related]
8. Preferential modification of GC boxes by benzo[a]pyrene-7,8-diol-9,10-epoxide. Kootstra A; Lew LK; Nairn RS; MacLeod MC Mol Carcinog; 1989; 1(4):239-44. PubMed ID: 2506885 [TBL] [Abstract][Full Text] [Related]
9. Analysis of site-specific binding of (+/-)-anti-benzo[a]pyrene diol epoxide to restriction fragments of pBR322 DNA via photochemical mapping. Dittrich KA; Krugh TR Chem Res Toxicol; 1991; 4(3):270-6. PubMed ID: 1912308 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects on the DNA binding of AP-1 transcription factor to an AP-1 binding site modified by benzo[a]pyrene 7,8-dihydrodiol 9,10-epoxide diastereomers. Persson AE; Pontén I; Cotgreave I; Jernström B Carcinogenesis; 1996 Sep; 17(9):1963-9. PubMed ID: 8824521 [TBL] [Abstract][Full Text] [Related]
11. Spectral differentiation and immunoaffinity capillary electrophoresis separation of enantiomeric benzo(a)pyrene diol epoxide-derived DNA adducts. Miksa B; Chinnappan R; Dang NC; Reppert M; Matter B; Tretyakova N; Grubor NM; Jankowiak R Chem Res Toxicol; 2007 Aug; 20(8):1192-9. PubMed ID: 17630708 [TBL] [Abstract][Full Text] [Related]
12. Low absolute mutagenic efficiency but high cytotoxicity of a non-bay region diol epoxide derived from benzo[a]pyrene. MacLeod MC; Adair G; Daylong A; Lew L; Humphrey RM Mutat Res; 1991 Dec; 261(4):281-93. PubMed ID: 1722283 [TBL] [Abstract][Full Text] [Related]
13. Immunoaffinity chromatography of carcinogen DNA adducts with polyclonal antibodies directed against benzo[a]pyrene diol-epoxide-DNA. Tierney B; Benson A; Garner RC J Natl Cancer Inst; 1986 Jul; 77(1):261-7. PubMed ID: 3459918 [TBL] [Abstract][Full Text] [Related]
15. The binding efficiency of polyclonal and monoclonal antibodies to DNA modified with benzo[a]pyrene diol epoxide is dependent on the level of modification. Implications for quantitation of benzo[a]pyrene-DNA adducts in vivo. Van Schooten FJ; Kriek E; Steenwinkel MJ; Noteborn HP; Hillebrand MJ; Van Leeuwen FE Carcinogenesis; 1987 Sep; 8(9):1263-9. PubMed ID: 3113753 [TBL] [Abstract][Full Text] [Related]
16. Differential efficiency of mutagenesis at three genetic loci in CHO cells by a benzo[a]pyrene diol epoxide. MacLeod MC; Adair G; Humphrey RM Mutat Res; 1988 May; 199(1):243-54. PubMed ID: 3129654 [TBL] [Abstract][Full Text] [Related]
17. Benzo[a]pyrene diol epoxide-DNA cis adduct formation through a trans chlorohydrin intermediate. Meehan T; Wolfe AR; Negrete GR; Song Q Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1749-54. PubMed ID: 9050850 [TBL] [Abstract][Full Text] [Related]
18. DNA repair in human cells: quantitative assessment of bulky anti-BPDE-DNA adducts by non-competitive immunoassays. Venkatachalam S; Denissenko M; Wani AA Carcinogenesis; 1995 Sep; 16(9):2029-36. PubMed ID: 7554050 [TBL] [Abstract][Full Text] [Related]
19. Quantification of (7S,8R)-dihydroxy-(9R,10S)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene adducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene. Ozbal CC; Skipper PL; Yu MC; London SJ; Dasari RR; Tannenbaum SR Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):733-9. PubMed ID: 10919745 [TBL] [Abstract][Full Text] [Related]
20. Inhibition by 6-mercaptopurine of the binding of a benzo(a)pyrene diol-epoxide to DNA in Chinese hamster ovary cells. MacLeod MC; Humphrey RM; Bickerstaff T; Daylong A Cancer Res; 1990 Jul; 50(14):4355-9. PubMed ID: 2114214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]